John Jay Boniface is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of predictive biomarkers, particularly in relation to pregnancy and preterm birth. With a total of 5 patents, Boniface's work is at the forefront of medical innovation.

Latest Patents

One of Boniface's latest patents focuses on biomarker pairs for predicting preterm birth. This disclosure provides a pair of isolated biomarkers selected from a specific group, which exhibits a change in reversal value between pregnant females at risk for preterm birth and term controls. The method involves measuring a reversal value for at least one pair of biomarkers in a biological sample obtained from the pregnant female to determine the probability for preterm birth. Another significant patent addresses pregnancy clock proteins for predicting due date and time to birth. This innovation offers compositions and methods that can predict due date and time to birth with significantly higher accuracy than current clinical methods.

Career Highlights

Throughout his career, Boniface has worked with prominent companies such as Sera Prognostics, Inc. and Prolexys Pharmaceuticals, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of predictive biomarkers.

Collaborations

Boniface has collaborated with notable coworkers, including Ashoka Dharmapriya Polpitiya and Tracey Cristine Fleischer. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

John Jay Boniface is a distinguished inventor whose work in predictive biomarkers has the potential to transform prenatal care. His innovative patents and collaborations highlight his commitment to improving health outcomes for pregnant women.

This text is generated by artificial intelligence and may not be accurate.